5CV — CureVac NV Cashflow Statement
0.000.00%
Last trade - 00:00
- €649.11m
- €481.89m
- €53.76m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -100 | -130 | -412 | -249 | -260 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 20.4 | 40.2 | -350 | 67.7 | 27.4 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -14.4 | 602 | 15.4 | -129 | -58.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -87 | 522 | -733 | -286 | -268 |
Capital Expenditures | -12.2 | -47.4 | -128 | -93.2 | -55.2 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 40.4 | 2.08 | 0 | -0.277 | 0 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 28.2 | -45.3 | -128 | -93.5 | -55.2 |
Financing Cash Flow Items | — | — | — | 66.5 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 68 | 820 | 345 | 63.2 | 231 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.3 | 1,292 | -511 | -316 | -93.3 |